These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9125763)

  • 21. Tuberous sclerosis: between genetic and physical analysis.
    Halley DJ
    Acta Genet Med Gemellol (Roma); 1996; 45(1-2):63-75. PubMed ID: 8872012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
    J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
    Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
    Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocyte abnormalities and senescence in the pathogenesis of idiopathic guttate hypomelanosis.
    Rani S; Kumar R; Kumarasinghe P; Bhardwaj S; Srivastava N; Madaan A; Parsad D
    Int J Dermatol; 2018 May; 57(5):559-565. PubMed ID: 29516488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberous sclerosis and tuberin: what do we learn from in situ localization data in the human brain?
    Wiestler OD; Wolf HK
    Brain Pathol; 1996 Oct; 6(4):376-7. PubMed ID: 8944310
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypermelanocytic guttate and macular segmental hypomelanosis.
    Westerhof W; Dingemans KP; Hulsmans RF
    Br J Dermatol; 2004 Sep; 151(3):701-5. PubMed ID: 15377363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation.
    Cao J; Tyburczy ME; Moss J; Darling TN; Widlund HR; Kwiatkowski DJ
    J Clin Invest; 2017 Jan; 127(1):349-364. PubMed ID: 27918305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confetti-like lesions with hyperkeratosis: a novel ultraviolet-induced hypomelanotic disorder?
    Loquai C; Metze D; Nashan D; Luger TA; Böhm M
    Br J Dermatol; 2005 Jul; 153(1):190-3. PubMed ID: 16029349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
    J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A third gene locus for tuberous sclerosis is closely linked to the phenylalanine hydroxylase gene locus.
    Fahsold R; Rott HD; Lorenz P
    Hum Genet; 1991 Nov; 88(1):85-90. PubMed ID: 1959929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of tuberous sclerosis complex.
    Franz DN
    Semin Pediatr Neurol; 1998 Dec; 5(4):253-68. PubMed ID: 9874853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis.
    Wataya-Kaneda M; Kaneda Y; Hino O; Adachi H; Hirayama Y; Seyama K; Satou T; Yoshikawa K
    Arch Dermatol Res; 2001 Sep; 293(9):460-9. PubMed ID: 11758789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients.
    Wilson PJ; Ramesh V; Kristiansen A; Bove C; Jozwiak S; Kwiatkowski DJ; Short MP; Haines JL
    Hum Mol Genet; 1996 Feb; 5(2):249-56. PubMed ID: 8824881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic guttate hypomelanosis. Ultrastructural study.
    Ortonne JP; Perrot H
    Arch Dermatol; 1980 Jun; 116(6):664-8. PubMed ID: 7377803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.
    Francalanci P; Diomedi-Camassei F; Purificato C; Santorelli FM; Giannotti A; Dominici C; Inserra A; Boldrini R
    Am J Surg Pathol; 2003 Oct; 27(10):1386-9. PubMed ID: 14508401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Black hair follicular dysplasia in Large Münsterländer dogs: clinical, histological and ultrastructural features.
    von Bomhard W; Mauldin EA; Schmutz SM; Leeb T; Casal ML
    Vet Dermatol; 2006 Jun; 17(3):182-8. PubMed ID: 16674733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
    Gutmann DH; Zhang Y; Hasbani MJ; Goldberg MP; Plank TL; Petri Henske E
    Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.